BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 17637772)

  • 1. Scripps Florida.
    Sheppard TL
    Nat Chem Biol; 2007 Aug; 3(8):451. PubMed ID: 17637772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Florida welcomes Scripps as critics predict big-money flop.
    Dalton R
    Nature; 2003 Nov; 426(6962):4. PubMed ID: 14603275
    [No Abstract]   [Full Text] [Related]  

  • 3. Wildlife campaigners fight planned site for Scripps Florida.
    Dalton R
    Nature; 2004 Sep; 431(7004):5. PubMed ID: 15343297
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug discovery alliances.
    Jones A; Clifford L
    Nat Rev Drug Discov; 2005 Oct; 4(10):807-8. PubMed ID: 16237845
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomedical research. Scripps and USC consider union, for money and prestige.
    Service R
    Science; 2014 Jun; 344(6191):1435-6. PubMed ID: 24970056
    [No Abstract]   [Full Text] [Related]  

  • 6. The brains behind blockbusters.
    Couzin J
    Science; 2005 Jul; 309(5735):728. PubMed ID: 16051786
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug development. Biotech thinking comes to academic medical centers.
    Alper J
    Science; 2003 Feb; 299(5611):1303-5. PubMed ID: 12610271
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug industry in "depression".
    Almog DM
    Med Sci Monit; 2005 Jan; 11(1):SR1-4. PubMed ID: 15614206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethics. Senate inquiry on research conflicts shifts to grantees.
    Kaiser J
    Science; 2008 Jun; 320(5884):1708. PubMed ID: 18583586
    [No Abstract]   [Full Text] [Related]  

  • 10. University-industry collaboration. Last of the big-time spenders?
    Lawler A
    Science; 2003 Jan; 299(5605):330-3. PubMed ID: 12531991
    [No Abstract]   [Full Text] [Related]  

  • 11. Glasgow and the West of Scotland region--bioscience buds beginning to bloom.
    O'Neill MF
    Drug Discov Today; 2006 May; 11(9-10):387-90. PubMed ID: 16635800
    [No Abstract]   [Full Text] [Related]  

  • 12. Surviving the blockbuster syndrome.
    Service RF
    Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490
    [No Abstract]   [Full Text] [Related]  

  • 13. The hunt for a new drug: five views from the inside.
    Mervis J
    Science; 2005 Jul; 309(5735):722. PubMed ID: 16051781
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharma moves ahead cautiously in China.
    Yidong G
    Science; 2005 Jul; 309(5735):735. PubMed ID: 16051788
    [No Abstract]   [Full Text] [Related]  

  • 15. Dundee: discovering life sciences.
    Tasker H
    Drug Discov Today; 2006 May; 11(9-10):379-82. PubMed ID: 16635798
    [No Abstract]   [Full Text] [Related]  

  • 16. The state of innovation in drug development.
    Kola I
    Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new Silk Road.
    Chien K; Chien L
    Nature; 2004 Mar; 428(6979):208-9. PubMed ID: 15014508
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical companies and ophthalmic research.
    Liesegang TJ; Schachat AP; Albert DA
    Ophthalmology; 2005 Mar; 112(3):363-5. PubMed ID: 15745760
    [No Abstract]   [Full Text] [Related]  

  • 19. Translational research: crossing the valley of death.
    Butler D
    Nature; 2008 Jun; 453(7197):840-2. PubMed ID: 18548043
    [No Abstract]   [Full Text] [Related]  

  • 20. Biomedical research. $300 million in private money for new investigators.
    Kaiser J
    Science; 2008 Mar; 319(5869):1469. PubMed ID: 18339907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.